A novel therapeutic approach for anaplastic thyroid cancer through inhibition of LAT1

A novel therapeutic approach is urgently needed for patients with anaplastic thyroid cancer (ATC) due to its fatal and rapid progress. We recently reported that ATC highly expressed MYC protein and blocking of MYC through its selective inhibitor, JQ1, decreased ATC growth and improved survival in pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Enomoto, Keisuke, Sato, Fuyuki, Tamagawa, Shunji, Gunduz, Mehmet, Onoda, Naoyoshi, Uchino, Shinya, Muragaki, Yasuteru, Hotomi, Muneki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787004/
https://www.ncbi.nlm.nih.gov/pubmed/31601917
http://dx.doi.org/10.1038/s41598-019-51144-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787004/
https://www.ncbi.nlm.nih.gov/pubmed/31601917
http://dx.doi.org/10.1038/s41598-019-51144-6

Ejemplares similares